Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0430
-0.0010 (-2.27%)
Feb 12, 2026, 4:10 PM AEST
Market Cap20.89M -8.3%
Revenue (ttm)11.07M +28.9%
Net Income-1.73M
EPS-0.00
Shares Out474.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume78,470
Average Volume338,637
Open0.0430
Previous Close0.0440
Day's Range0.0430 - 0.0430
52-Week Range0.0330 - 0.0620
Beta1.15
RSI48.93
Earnings DateFeb 26, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements